GlassScriptPhysician profile
Allison M Donovan
NPI 1306486030
$2,317.07
in general payments reported to CMS, 2019-2025
12 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what 86% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $237 · 2023: $565 · 2024: $192 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045 · Travel and Lodging: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.18 |
| Travel and Lodging | $1,034.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $1,189.95 | 2025 | Neurostar Tms Therapy System |
| Otsuka America Pharmaceutical, INC. | $292.01 | 2022-2023 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Abbvie INC. | $242.67 | 2022-2025 | |
| Corium, LLC | $149.03 | 2022-2024 | Azstarys |
| Amgen INC. | $109.21 | 2025 | Evenity |
| Inspire Medical Systems, INC. | $80.22 | 2024 | Inspire |
| Ironshore Pharmaceuticals INC. | $77.34 | 2022-2023 | Jornay Pm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.37 | 2023 | Jardiance |
| Abbott Laboratories | $40.12 | 2024 | Freestyle Libre 3 |
| Novo Nordisk INC | $40.12 | 2022 | |
| Neurocrine Biosciences, INC. | $17.09 | 2022 | |
| Tris Pharma INC | $13.94 | 2023 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.